Evaluation of the NovaLisa™ Leishmania Infantum IgG ELISA in A Reference Diagnostic Laboratory in A Non-Endemic Country

Anti-Leishmania antibodies may be detectable in patients with leishmaniasis. Here, we compared a commercial enzyme-linked immunosorbent assay (ELISA) for the detection of anti-Leishmania antibodies, with an immunofluorescence antibody test (IFAT) that is no longer commercially available. Eighty-six...

Descripción completa

Detalles Bibliográficos
Autores principales: Stensvold, Christen Rune, Høst, Amalie Vang, Belkessa, Salem, Nielsen, Henrik Vedel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640698/
https://www.ncbi.nlm.nih.gov/pubmed/31544826
http://dx.doi.org/10.3390/antib8010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640698/
https://www.ncbi.nlm.nih.gov/pubmed/31544826
http://dx.doi.org/10.3390/antib8010020

Ejemplares similares